These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7152425)

  • 41. Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
    Haschke F; Wimmer M; Parth K
    Padiatr Padol; 1981; 16(3):317-26. PubMed ID: 7254888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modifications of bile secretion and liver microsomal enzymes by aldosterone and spironolactone.
    Afifi F; Peignoux M; Auclair C
    Hepatogastroenterology; 1980 Feb; 27(1):9-16. PubMed ID: 7203360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of Aldatense on laboratory tests. Comparison with a reference population].
    Hitz J; Steinmetz J; Henny J; Siest G
    Ann Biol Clin (Paris); 1984; 42(4):289-93. PubMed ID: 6149712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F; Remonda G; Morachioli N; Pugnani M
    Ann Osp Maria Vittoria Torino; 1982; 25(1-6):61-70. PubMed ID: 7185311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.
    Angeli P; Dalla Pria M; De Bei E; Albino G; Caregaro L; Merkel C; Ceolotto G; Gatta A
    Hepatology; 1994 Jan; 19(1):72-9. PubMed ID: 8276370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of aldosterone and spironolactone on the proliferation and collagen synthesis of hepatic stellate cells in rats].
    Yao JF; Yao XX; Fang HM; Cui DL; Bai WY
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1823-5. PubMed ID: 14642092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphocyte function tests in cirrhotic patients under treatment with spironolactone and potassium canrenoate.
    Cuppone R; Del Vecchio S; Zanninelli G; Delle Monache M; Ulissi A; Tavanti A; Angeloni A; Ricci GL
    J Int Med Res; 1988; 16(6):436-42. PubMed ID: 3266156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in nitrogen balance during the period following abdominal surgery and use of an injectable anti-aldosterone].
    Metivier Y; Guinot P; Saizy R; Meillaud J; Lioret N
    Agressologie; 1976; 17(5):313-8. PubMed ID: 1015551
    [No Abstract]   [Full Text] [Related]  

  • 49. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response.
    Le Moëllic C; Ouvrard-Pascaud A; Capurro C; Cluzeaud F; Fay M; Jaisser F; Farman N; Blot-Chabaud M
    J Am Soc Nephrol; 2004 May; 15(5):1145-60. PubMed ID: 15100355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome].
    Russo R; Schena FP; Colombo Pirola L
    Clin Ter; 1984 Apr; 109(1):23-9. PubMed ID: 6233076
    [No Abstract]   [Full Text] [Related]  

  • 51. [Evaluation of K-canrenoate in post-surgical treatment of open heart paediatric surgery (author's transl)].
    Capuani A; Bernabei M; Pasque A; Eufrate S
    G Ital Cardiol; 1980; 10(9):1148-55. PubMed ID: 7461364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Production of aldosterone by rat mesangial cell and the accumulation of extracellular matrix induced by aldosterone].
    Lai LY; Gu Y; Chen J; Yu SQ; Ma J; Yang HC; Lin SY
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(21):1900-5. PubMed ID: 14642076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study of the inotropic effect of potassium-canrenoate by systolic time intervals technique (author's transl)].
    Vitolo E; Larovere MT; Gambini E; Rusconi F; Vitali GM
    G Ital Cardiol; 1980; 10(10):1360-5. PubMed ID: 7239083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
    Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
    Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide.
    Balfagón G; Márquez-Rodas I; Alvarez Y; Alonso MJ; Cachofeiro V; Salaices M; Lahera V
    Regul Pept; 2004 Aug; 120(1-3):253-60. PubMed ID: 15177944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
    Sharabi Y; Adler E; Shamis A; Nussinovitch N; Markovitz A; Grossman E
    Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats.
    Lal A; Veinot JP; Leenen FH
    Cardiovasc Res; 2004 Dec; 64(3):437-47. PubMed ID: 15537497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].
    Kirsch R
    Schweiz Rundsch Med Prax; 1975 Nov; 64(44):1414-7. PubMed ID: 1236699
    [No Abstract]   [Full Text] [Related]  

  • 59. Disturbances of electrical activity of the brain induced by the spirolactone derivative potassium canrenoate.
    Simon O; Mertin J; Schmiedek P
    Electroencephalogr Clin Neurophysiol; 1973 Aug; 35(2):165-71. PubMed ID: 4124608
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of a simple fluorometric 11-hydroxycorticosteroids assay in the assessment of spironolactone-metabolite level in plasma and urine.
    Radó JP; Szende L; Takó J; Nagy O
    Endokrinologie; 1974 Nov; 64(1):22-32. PubMed ID: 4466654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.